These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 22704116

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. New clinical evidence of silodosin, an α(1A) selective adrenoceptor antagonist, in the treatment for lower urinary tract symptoms.
    Yoshida M, Kudoh J, Homma Y, Kawabe K.
    Int J Urol; 2012 Apr; 19(4):306-16. PubMed ID: 22251148
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Lower urinary tract symptoms - current management in older men.
    Arianayagam M, Arianayagam R, Rashid P.
    Aust Fam Physician; 2011 Oct; 40(10):758-67. PubMed ID: 22003476
    [Abstract] [Full Text] [Related]

  • 28. [The efficacy of Gosyajinkigan for pollakisuria].
    Watanabe A, Akashi T, Fujiuchi Y, Mizuno I, Nagakawa O, Fuse H.
    Hinyokika Kiyo; 2006 Mar; 52(3):197-201. PubMed ID: 16617873
    [Abstract] [Full Text] [Related]

  • 29. Repeated intensification of lower urinary tract symptoms in the patient with benign prostatic hyperplasia during bisoprolol treatment.
    Sein Anand J, Chodorowski Z, Hajduk A.
    Przegl Lek; 2005 Mar; 62(6):522-3. PubMed ID: 16225113
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A prospective, randomized, controlled, multicenter study of naftopidil for treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia: 75 mg once daily in the evening compared to 25 mg thrice daily.
    Tsuritani S, Nozaki T, Okumura A, Kimura H, Kazama T.
    Urol Int; 2010 Mar; 85(1):80-7. PubMed ID: 20516676
    [Abstract] [Full Text] [Related]

  • 39. Association between switching prescribed drugs for lower urinary tract symptoms and independence of urination in post-stroke patients: A retrospective cohort study.
    Sumiya K, Shogenji M, Ikenaga Y, Ogawa Y, Hirako K, Fujita A, Shimada T, Hashimoto M, Masuda A, Nagamoto T, Tamai I, Ogura H, Toyama T, Wada T, Sai Y.
    J Stroke Cerebrovasc Dis; 2023 Dec; 32(12):107419. PubMed ID: 37839304
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.